June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Target 5000: Genetic characterisation of a cohort of inherited retinal degeneration (IRD) patients
Author Affiliations & Notes
  • Adrian Dockery
    The School of Genetics & Microbiology, Trinity College Dublin, Dublin, Leinster, Ireland
  • Matthew Carrigan
    The School of Genetics & Microbiology, Trinity College Dublin, Dublin, Leinster, Ireland
  • Conor Patrick Malone
    Research Foundation, The Royal Victoria Eye and Ear Hospital, Dublin, Ireland
  • Emma Duignan
    Research Foundation, The Royal Victoria Eye and Ear Hospital, Dublin, Ireland
  • David J Keegan
    The Mater Misericordiae Hospital, Dublin, Ireland
  • Kirk Stephenson
    The Mater Misericordiae Hospital, Dublin, Ireland
  • Giuliana Silvestri
    Department of Ophthalmology, The Royal Victoria Hospital, Belfast, United Kingdom
    Centre for Experimental Medicine, Queen’s University Belfast, Belfast, United Kingdom
  • Andrew Green
    Our Lady’s Children’s Hospital, Dublin, Ireland
  • John McCourt
    RCSI Clinical Research Centre, Beaumont Hospital, Dublin, Ireland
  • Peter Humphries
    The School of Genetics & Microbiology, Trinity College Dublin, Dublin, Leinster, Ireland
  • Paul F Kenna
    The School of Genetics & Microbiology, Trinity College Dublin, Dublin, Leinster, Ireland
    Research Foundation, The Royal Victoria Eye and Ear Hospital, Dublin, Ireland
  • Jane G Farrar
    The School of Genetics & Microbiology, Trinity College Dublin, Dublin, Leinster, Ireland
  • Footnotes
    Commercial Relationships   Adrian Dockery, None; Matthew Carrigan, None; Conor Malone, None; Emma Duignan, None; David Keegan, None; Kirk Stephenson, None; Giuliana Silvestri, None; Andrew Green, None; John McCourt, None; Peter Humphries, None; Paul Kenna, None; Jane Farrar, None
  • Footnotes
    Support  Fighting Blindness Ireland, Health Research Board, Science Foundation Ireland, Medical Research Charities Group.
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 2752. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Adrian Dockery, Matthew Carrigan, Conor Patrick Malone, Emma Duignan, David J Keegan, Kirk Stephenson, Giuliana Silvestri, Andrew Green, John McCourt, Peter Humphries, Paul F Kenna, Jane G Farrar; Target 5000: Genetic characterisation of a cohort of inherited retinal degeneration (IRD) patients. Invest. Ophthalmol. Vis. Sci. 2017;58(8):2752.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : While clinical trials are in progress for patients with inherited retinal degenerations (IRDs), many such trials require patients to have a known causative mutation to participate in these trials. The Target 5000 research project aims to genetically characterise the estimated 5,000 people in Ireland with IRDs.

Methods : The IRD patient cohort used in the study has been obtained via a collaborative network of ophthalmologists whereby if an IRD is suspected given consent, a DNA sample is taken and provided to a central laboratory for genetic analysis. The study seeks to detect previously identified, together with as yet undiscovered, pathological mutations in a panel of known retinal degeneration genes utilizing target capture next generation sequencing (NGS). The study to date includes over 700 IRD patients from more than 400 pedigrees.

Results : To date, as part of Target 5000, over 10% of the Irish IRD population has been sequenced providing real insights into the genetic architecture of IRDs in Ireland. Target 5000 offers not only a chance to discover new relevant and pathogenic mutations, but is vital to providing patients with information regarding the underlying genetic pathogenesis of their disease. Over 50 novel IRD mutations have been discovered to date, as well as some previously ambiguous disease phenotypes resolved.

Conclusions : The aim of the study is to genetically characterise patients with IRDs in Ireland and in principle potentially enable clinical trials to be more accessible for some patients analysed where appropriate. Thus far, during the course of the study, genetic analysis of IRD patients has helped to resolve ambiguous phenotypes and to identify causative mutations in approximately 60% of cases. The growing body of data from NGS studies of IRDs globally should facilitate better correlations between genotype and phenotype and refine methods for diagnoses and prognoses.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×